Sanjivani Paranteral Limited (BOM:531569)
India
· Delayed Price · Currency is INR 164.05
-3.00 (-1.80%)
At close: Apr 28, 2026
Sanjivani Paranteral Revenue
Sanjivani Paranteral had revenue of 220.63M INR in the quarter ending December 31, 2025, with 27.17% growth. This brings the company's revenue in the last twelve months to 736.34M, up 13.67% year-over-year. In the fiscal year ending March 31, 2025, Sanjivani Paranteral had annual revenue of 700.99M with 28.83% growth.
Revenue (ttm)
736.34M
Revenue Growth
+13.67%
P/S Ratio
2.74
Revenue / Employee
18.41M
Employees
40
Market Cap
2.02B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 700.99M | 156.88M | 28.83% |
| Mar 31, 2024 | 544.11M | 189.19M | 53.31% |
| Mar 31, 2023 | 354.92M | 48.79M | 15.94% |
| Mar 31, 2022 | 306.13M | 55.13M | 21.96% |
| Mar 31, 2021 | 251.00M | 87.44M | 53.46% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Aayush Wellness | 1.29B |
| Oxygenta Pharmaceutical | 1.13B |
| Parnax Lab | 2.28B |
| BDH Industries | 847.44M |
| Astonea Labs | 1.17B |
| Gennex Laboratories | 1.52B |
| Everest Organics | 1.89B |
| Ambalal Sarabhai Enterprises | 2.03B |
Sanjivani Paranteral News
- 2 months ago - Q3 2026 Sanjivani Paranteral Ltd Earnings Call Transcript - GuruFocus
- 5 months ago - Q2 2026 Sanjivani Paranteral Ltd Earnings Call Transcript - GuruFocus